Coronary vasospasm is a sudden, temporary tightening of a coronary artery that chokes off blood flow to the heart muscle, sometimes severely enough to trigger a heart attack or cardiac arrest. Unlike the gradual cholesterol buildup most people associate with heart disease, vasospasm can strike arteries that look perfectly clean on an angiogram. The condition involves a complex interplay between the artery’s inner lining and its muscular wall, and it remains underdiagnosed partly because the spasm may have resolved by the time a patient reaches the hospital.
What Happens Inside the Artery During a Spasm
A coronary artery has two key layers relevant to vasospasm. The endothelium, the thin inner lining, normally produces nitric oxide, a molecule that keeps the artery relaxed and open. Beneath it sits a layer of smooth muscle cells that can contract or relax in response to chemical signals. Vasospasm occurs when those signals go wrong on both fronts.
In people prone to coronary spasm, the endothelium produces less nitric oxide than it should. Researchers have confirmed that spasm-prone arteries have a measurable deficiency in nitric oxide activity, which makes the artery overly sensitive to anything that signals it to constrict and unusually responsive to nitroglycerin, a drug that supplies nitric oxide externally.1PubMed. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina At the same time, oxidative stress is elevated and markers of low-grade inflammation like C-reactive protein tend to be higher in these patients.2PubMed Central. Recent insights into the mechanisms of vasospastic angina
On the smooth muscle side, a signaling pathway involving a protein called Rho-kinase appears to be the central troublemaker. When Rho-kinase activity is cranked up, the smooth muscle cells in the artery wall contract more forcefully than they should and resist relaxing.3PubMed. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina Inflammatory molecules like angiotensin II and interleukin-1 beta have been shown to boost Rho-kinase expression in human coronary smooth muscle cells, creating a feedback loop where inflammation begets more contraction.4PubMed. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells The result is a hyperreactive artery: one that can clamp down hard, fast, and sometimes with little obvious provocation. How much each component contributes in any given patient is still debated, but researchers increasingly view endothelial dysfunction and smooth muscle hyperreactivity as two sides of the same coin.5PubMed Central. Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity
Symptoms and When They Strike
The hallmark of vasospastic angina, historically called Prinzmetal’s or variant angina, is chest pain that occurs at rest rather than during exercise. On an electrocardiogram taken during an episode, the classic finding is a transient rise in the ST segment, the same pattern seen during a full-blown heart attack, which resolves once the spasm lets up.6PubMed Central. Prinzmetal angina: An unrecognized cause of recurrent ST elevation myocardial infarction During spasm episodes, dangerous heart rhythms are not rare. In one early study of eight patients with variant angina, half developed serious rhythm disturbances including ventricular tachycardia and heart block during their pain episodes.7American Heart Journal. Prinzmetal’s variant angina: A clinical and electrocardiographic study
There is a strong nocturnal and early-morning pattern. Studies of the autonomic nervous system in these patients reveal that a shift toward more sympathetic (fight-or-flight) activity and less parasympathetic (rest-and-digest) activity during the nighttime hours plays a role in triggering spasm. In patients with variant angina that occurs during sleep, this sympathetic surge without the usual parasympathetic counterbalance appears to be a key mechanism.8PubMed. Alterations of autonomic nervous activity preceding nocturnal variant angina: sympathetic augmentation with parasympathetic impairment In patients who have spasm in multiple coronary arteries simultaneously, the nighttime drop in sympathetic tone that healthy people experience is blunted, meaning their arteries never fully relax.9PubMed. Circadian variation of autonomic nervous activity in patients with multivessel coronary spasm
Perhaps the most unsettling finding is that the majority of ischemic episodes in vasospastic angina patients produce no symptoms at all. Ambulatory heart monitoring studies have shown that most spasm-related drops in blood flow occur silently, often during sleep, and are detectable only on continuous electrocardiographic recordings.10PubMed Central. Editorial: Silent myocardial ischemia due to coronary artery spasm This means patients can have significant, repeated cardiac ischemia without ever feeling chest pain.
Risk Factors and Triggers
Smoking is the most consistently identified modifiable risk factor. It damages the endothelium, reduces nitric oxide production, and promotes oxidative stress, all of which set the stage for spasm.11PubMed Central. Recent insights into the mechanisms of vasospastic angina Cocaine is another potent trigger. It constricts coronary arteries by stimulating alpha-adrenergic receptors on the smooth muscle and simultaneously driving down nitric oxide production while boosting levels of endothelin, a powerful vasoconstrictor. Even recreational doses can set off spasm.12PubMed Central. Sniff of coke breaks the heart: cocaine-induced coronary vasospasm aggravated by therapeutic hypothermia and vasopressors after aborted sudden cardiac death
Certain medications used in cancer treatment, particularly the chemotherapy drug 5-fluorouracil, are recognized causes of coronary vasospasm. The proposed mechanisms include direct endothelial damage followed by clot formation, spasm of the coronary arteries, and direct toxic effects on heart muscle cells.13PubMed Central. Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions This is an underappreciated issue in oncology, and patients receiving 5-fluorouracil-based regimens who develop chest pain need evaluation for vasospasm.
Beta-blockers, commonly prescribed for high blood pressure and other heart conditions, can paradoxically worsen or even trigger vasospasm. By blocking the beta-adrenergic receptors that normally promote vessel relaxation, they leave the alpha-adrenergic receptors unopposed, tipping the balance toward constriction. In one documented case, a patient developed recurrent multi-vessel spasm during beta-blocker use that resolved completely after the beta-blocker was stopped and replaced with a calcium channel blocker.14PubMed Central. Multi-vessel Coronary Vasospasm after Beta-blocker Administration
A Genetic Component in East Asian Populations
Vasospastic angina is significantly more common in East Asian populations than in Western ones, and researchers have identified a genetic factor that helps explain this disparity. A variant form of the enzyme aldehyde dehydrogenase 2, called ALDH2*2, is prevalent among East Asians. People who carry this variant are the same individuals who flush red when they drink alcohol. This enzyme normally clears toxic aldehydes from the body, and when it is deficient, those reactive compounds accumulate and damage the vascular endothelium. Studies in Japanese patients have confirmed that carrying the ALDH2*2 variant is associated with coronary spastic angina.15PubMed. East Asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: possible roles of reactive aldehydes and implications of alcohol flushing syndrome The risk compounds when the genetic variant is paired with smoking, which generates additional toxic aldehydes and further overwhelms the already-deficient enzyme.16Circulation Journal. Variant Aldehyde Dehydrogenase 2 (ALDH2*2) in East Asians Interactively Exacerbates Tobacco Smoking Risk for Coronary Spasm ― Possible Role of Reactive Aldehydes ―
Epicardial Versus Microvascular Spasm
Not all coronary vasospasm is the same. The large arteries visible on a standard angiogram are epicardial vessels, and spasm of these arteries is what most people picture: a big artery clamping down. But spasm can also occur in the tiny arteries buried within the heart muscle itself, a condition called microvascular spasm. During provocation testing, epicardial spasm is defined as a near-total narrowing of a visible artery, while microvascular spasm produces chest pain and electrocardiographic changes without any visible artery clamping down.17PubMed Central. Prevalence of Coronary Microvascular Dysfunction and Epicardial Spasm in Patients With Angina and Myocardial Bridge
A study of 120 patients who underwent provocation testing found that roughly two-thirds had epicardial spasm and the remaining third had microvascular spasm. The two groups looked different clinically: epicardial spasm was more common in men, in smokers, and in patients with diffuse atherosclerosis who had presented with a heart attack despite open coronary arteries. Microvascular spasm was more common in patients with stable chest pain and showed an association with diastolic dysfunction, a stiffness problem in the heart’s filling chambers.18PubMed. Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries The distinction matters because the two forms may respond differently to treatment and carry different long-term implications.
Vasospasm and Heart Attacks With Open Arteries
When someone has a heart attack but their angiogram shows no significant blockage, the condition is known as MINOCA (myocardial infarction with non-obstructive coronary arteries). It is a frustrating diagnosis for patients and doctors alike. Growing evidence indicates that coronary spasm and vasomotor dysfunction may underlie more than half of MINOCA cases and represent an important cause of chronic chest pain in the outpatient setting as well.19EuroIntervention. Coronary spasm and vasomotor dysfunction as a cause of MINOCA
In one series of nearly 1,000 patients presenting with suspected heart attacks, 62 met criteria for MINOCA. Of those, spasm-induced heart attack accounted for about three-quarters of cases after provocation testing was performed.20PubMed. Coronary artery spasm-induced acute myocardial infarction in patients with myocardial infarction with non-obstructive coronary arteries That finding highlights how frequently vasospasm is the culprit behind what would otherwise remain an unexplained heart attack. Without specific testing for spasm, many of these patients leave the hospital with no clear explanation and no targeted treatment.
How Coronary Vasospasm Is Diagnosed
Because spasm is episodic and often resolves before imaging can capture it, diagnosis typically requires a provocation test. During a cardiac catheterization, the cardiologist injects acetylcholine or ergonovine directly into the coronary arteries and watches for spasm on the angiogram, while monitoring for chest pain and ECG changes. A positive test means the artery narrows severely in response to the drug, reproducing the patient’s symptoms.
This sounds alarming, and patients understandably worry about deliberately triggering a spasm in a catheterization lab. However, large reviews of provocation testing data have consistently shown it to be safe. A pooled analysis found that major complications occurred in less than one percent of tests, and minor complications in under five percent. No deaths were reported. Acetylcholine testing had a somewhat higher complication rate than ergonovine, but both remained low.21PubMed. Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm Some centers now use a sequential approach, injecting acetylcholine first and then ergonovine if the first agent is negative. This strategy caught additional positive cases in about 14 percent of patients who had tested negative to acetylcholine alone, with a similarly low major complication rate.22PubMed Central. Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing
Treatment With Calcium Channel Blockers
Calcium channel blockers are the backbone of vasospastic angina treatment. These drugs relax arterial smooth muscle by reducing the calcium influx that drives contraction. A systematic review comparing different calcium channel blockers found that both diltiazem and nifedipine reduced the frequency of chest pain, with benefits apparent by about four weeks. Over 12 weeks, diltiazem showed a somewhat better tendency to reduce episode frequency. Amlodipine, another member of this drug class, also improved symptoms.23BMJ Open. Comparison of various calcium antagonist on vasospastic angina: a systematic review Long-acting formulations that patients only need to take once or twice daily tend to improve both adherence and effectiveness.
Nitrates, which supply nitric oxide directly, are the other standard therapy, used both for acute relief and long-term prevention. The important point for patients and prescribers to remember is that beta-blockers, a reflexive first-line drug in many cardiac situations, can make vasospasm worse by leaving alpha-mediated vasoconstriction unopposed. As noted earlier, documented cases of beta-blocker-induced multi-vessel spasm underscore the need to identify vasospasm before defaulting to standard cardiac medication regimens.24PubMed Central. Multi-vessel Coronary Vasospasm after Beta-blocker Administration
Rho-Kinase Inhibitors for Refractory Spasm
For patients whose spasm does not respond to calcium channel blockers and nitrates, a newer approach targets the Rho-kinase pathway directly. Fasudil, a Rho-kinase inhibitor, has been used in Japan and has shown striking results in case reports of refractory vasospasm. In one case following cardiac surgery, coronary spasm persisted despite treatment with calcium channel blockers, nitrates, and nicorandil, but resolved with fasudil administration without causing problematic drops in blood pressure.25PubMed Central. Relief of vasospasm with fasudil after off-pump coronary artery bypass grafting: a case study In another case of refractory vasospasm following cardiac arrest, continuous low-dose fasudil controlled the spasm when conventional drugs could not, likely by both suppressing Rho-kinase activity and restoring nitric oxide production from the endothelium.26PubMed Central. Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
Fasudil is not widely available outside Japan, and the evidence supporting it comes mostly from case reports and small series rather than large randomized trials. Still, it represents the most mechanistically rational advance in vasospasm treatment in years, given that upregulated Rho-kinase appears to be the central driver of smooth muscle hypercontraction in this condition. Whether Rho-kinase inhibitors eventually become standard therapy will depend on larger trials and regulatory decisions in Western countries.
Kounis Syndrome and Allergic Vasospasm
One of the stranger chapters in vasospasm medicine involves allergic reactions triggering coronary spasm. Known as Kounis syndrome, this occurs when inflammatory mediators released during anaphylaxis or a severe allergic reaction, including histamine, tryptase, and platelet-activating factor, directly provoke the coronary arteries to spasm.27PubMed Central. Allergic acute coronary syndrome (Kounis syndrome) Triggers have included insect stings, drug allergies, and even food reactions. The inflammatory mediators released by mast cells and other immune cells act on the coronary arteries in much the same way that the inflammatory stimuli discussed earlier boost Rho-kinase activity and endothelial dysfunction.28PubMed. Kounis syndrome: a new twist on an old disease
Kounis syndrome is not limited to the heart. It can affect mesenteric and cerebral arteries as well, accompanied by skin, respiratory, and vascular symptoms of allergy.29PubMed Central. Kounis Syndrome—not a Single-organ Arterial Disorder but a Multisystem and Multidisciplinary Disease The condition is probably underdiagnosed because when someone collapses during a severe allergic reaction, the focus is on treating the allergy, and cardiac involvement may be attributed to hemodynamic shock rather than primary coronary spasm.
Cardiac Arrest and the Role of Implantable Defibrillators
Although vasospastic angina is often described as a benign condition relative to atherosclerotic heart disease, that characterization can be dangerously misleading. In one study following 150 patients admitted for vasospastic angina, about 7 percent experienced sudden cardiac arrest during the follow-up period, and the mortality rate among those who arrested was 30 percent.30REC: CardioClinics. Predictors of sudden cardiac arrest in vasospastic angina Among 1,000 consecutive out-of-hospital cardiac arrest patients in another series, vasospasm was identified as the cause in a subset of those successfully resuscitated from cardiovascular events.31Circulation Journal. Characteristics of Patients With Cardiac Arrest Caused by Coronary Vasospasm
Interestingly, when vasospasm patients who survive an initial cardiac arrest are compared to patients whose arrest was caused by coronary blockages, the vasospasm group initially appears to fare better in raw survival numbers. However, after adjusting for other patient characteristics, the outcomes were comparable, suggesting that surviving the first arrest does not make a vasospasm patient inherently safer going forward.32PubMed Central. Vasospasm-related Sudden Cardiac Death Has Outcomes Comparable with Coronary Stenosis in Out-of-Hospital Cardiac Arrest
For patients who have already survived a vasospasm-related cardiac arrest, implantable cardioverter-defibrillators have proven their worth. In one cohort of 33 patients who received ICDs after a spasm-related arrest, every patient who had a subsequent life-threatening rhythm was successfully shocked back by the device.33PubMed Central. Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm Current evidence supports ICD placement in this population as secondary prevention, since even aggressive medical therapy with multiple vasodilators may not fully prevent recurrent life-threatening arrhythmias.34PubMed. Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death The message is sobering: vasospasm can kill, and in the highest-risk patients, medication alone is not always enough.